PROFESSIONAL EDITION

The largest community of pharma leaders

Industry News

Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Global Threat of Multi-drug Resistant Bacteria

PITTSBURGH--(BUSINESS WIRE)--Peptilogics, a clinical-stage biotechnology company developing a computational peptide therapeutics discovery platform and novel best-in-class anti-infective compounds, announced today that it has entered...

Recent Articles